Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
112.12
-0.17 (-0.15%)
At close: May 01, 2025, 2:57 PM
Axsome Therapeutics Revenue
Axsome Therapeutics reported an annual revenue of $385.69M, reflecting a 42.53% growth. For the quarter ending December 31, 2024, Axsome Therapeutics generated $118.77M in revenue.
Revenue (ttm)
$385.69M
Revenue Growth
42.53%
Price / Sales Ratio
10.51
Revenue / Employee
$564.7K
Employees
683
Market Cap
5.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 385.69M | +42.53% |
| Dec 31, 2023 | 270.6M | +440.80% |
| Dec 31, 2022 | 50.04M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |